Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

PURPOSE: To evaluate the effect and tolerance of oral mineralocorticoid antagonists, eplerenone and/or spironolactone, in recalcitrant central serous chorioretinopathy. METHODS: Retrospective consecutive observational case series. Primary outcome measures included central macular thickness (CMT, μm)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Eric K, Almeida, David RP, Roybal, C Nathaniel, Niles, Philip I, Gehrs, Karen M, Sohn, Elliott H, Boldt, H Culver, Russell, Stephen R, Folk, James C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540165/
https://www.ncbi.nlm.nih.gov/pubmed/26316684
http://dx.doi.org/10.2147/OPTH.S86778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540165/
https://www.ncbi.nlm.nih.gov/pubmed/26316684
http://dx.doi.org/10.2147/OPTH.S86778

Ejemplares similares